EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieVergleichsstudie

Mandibular Advancement Device versus CPAP in Severe Obstructive Sleep Apnea

J T Colpani, Y-H Ou, A M Kosasih, F K F Lee, S-P Chan, H H Tan, R C W Wong iD, C W Chin, P A Cistulli, C-H Lee iD

Journal of Dental Research · 2026

DOI: 10.1177/00220345251361796 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Dental Research, 2026. Verfasst von J T Colpani und 9 weiteren Autor:innen. Beteiligte Einrichtung: Discipline of Endodontics, Operative Dentistry and Prosthodontics, Faculty of Dentistry, National University of Singapore, Singapore. Hauptthemen laut MEDLINE: Mandibular Advancement, Sleep Apnea, Obstructive, Continuous Positive Airway Pressure. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 26 Literaturangaben. Gefördert von: National Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Severe obstructive sleep apnea (OSA) is linked to adverse cardiovascular outcomes. While continuous positive airway pressure (CPAP) is the standard treatment, mandibular advancement devices (MADs) offer an alternative. This substudy of a randomized trial compared the effectiveness of MADs versus CPAP on 24-h ambulatory blood pressure (BP), sleep-related quality of life, myocardial remodeling, ambulatory heart rhythm, and biomarkers in severe OSA. A total of 144 participants were randomized to MAD ( n = 73) or CPAP ( n = 71) for 12 mo. Median nightly usage was 5.4 (2.9–6.5) h for the MAD group (≥6 h/night: 56.1%) and 4.9 (4.0–6.0) h for the CPAP group (≥6 h/night: 28.3%). The apnea-hypopnea index at baseline and 6 mo was 44.0 (37.6–59.2) and 20.9 (11.7–31.9) events/h in the MAD group and 50.7 (40.7–59.8) and 2.1 (1.2–3.4) events/h in the CPAP group, respectively. MAD treatment reduced asleep mean BP (−4.7 mm Hg, 95% confidence interval [CI]: −8.3 to −4.0, P = 0.015), asleep systolic BP (−2.0 mm Hg, 95% CI: −10.0 to −4.0, P = 0.047), and asleep diastolic BP (−4.0 mm Hg, 95% CI: −9.0 to −3.0, P = 0.007), whereas CPAP showed no significant changes. The between-group differences favored MAD in asleep mean BP (−3.70 mm Hg, 95% CI: −7.40 to 0.00, P = 0.050) and asleep systolic BP (−4.78 mm Hg, 95% CI: −9.51 to 0.04, P = 0.048). Both improved sleep-related quality of life, although CPAP had a slightly greater effect on the Epworth Sleepiness Scale (Δ1.63, 95% CI: 0.45 to 2.81, P = 0.007). No significant changes were observed in cardiac magnetic resonance imaging parameters, ambulatory heart rhythm, or biomarkers. Adverse effects included jaw pain (14.8%) and teeth discomfort (8.2%) with MAD, whereas CPAP users reported dry mouth (50.8%), nasal congestion (23.0%), and air leakage (29.5%). In conclusion, these findings suggested MAD could be an acceptable and effective treatment for patients with severe OSA and hypertension. The study was registered at Clinicaltrials.gov (NCT04119999).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mandibular AdvancementSleep Apnea, ObstructiveContinuous Positive Airway PressureHumansMaleFemaleMiddle AgedQuality of LifeAdultBlood PressureTreatment OutcomeHeart RatePolysomnographyBlood Pressure Monitoring, AmbulatoryAged

Stichwörter der Autor:innen

Cardiovascular riskblood pressurecontinuous positive airway pressurehypertensionmandibular advancement devicesquality of life

Autor:innen und Institutionen

  • Discipline of Endodontics, Operative Dentistry and Prosthodontics, Faculty of Dentistry, National University of Singapore, Singapore.
  • Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
  • Department of Cardiology, National University Heart Centre, Singapore.
  • Discipline of Oral and Maxillofacial Surgery, Faculty of Dentistry, National University of Singapore, Singapore.
  • Department of Cardiology, National Heart Centre Singapore, Singapore.
  • Sleep Research Group, Charles Perkins Centre & Northern Clinical School, Faculty of Medicine and Health, University of Sydney, Camperdown, New South Wales, Australia.

ORCID-Profile: R C W Wong, C-H Lee

Förderung

  • National Medical Research Council

Zitieren

APA

Colpani, J. T., Ou, Y. H., Kosasih, A. M., Lee, F. K. F., Chan, S. P., Tan, H. H., Wong, R. C. W., Chin, C. W., Cistulli, P. A., & Lee, C. H. (2026). Mandibular Advancement Device versus CPAP in Severe Obstructive Sleep Apnea. Journal of Dental Research. https://doi.org/10.1177/00220345251361796

Vancouver

Colpani JT, Ou YH, Kosasih AM, Lee FKF, Chan SP, Tan HH, et al. Mandibular Advancement Device versus CPAP in Severe Obstructive Sleep Apnea. Journal of Dental Research. 2026. doi:10.1177/00220345251361796

BibTeX
@article{Colpani2026,
  author = {Colpani, J T and Ou, Y-H and Kosasih, A M and Lee, F K F and Chan, S-P and Tan, H H and Wong, R C W and Chin, C W and Cistulli, P A and Lee, C-H},
  title = {Mandibular Advancement Device versus CPAP in Severe Obstructive Sleep Apnea},
  journal = {Journal of Dental Research},
  year = {2026},
  doi = {10.1177/00220345251361796}
}
Kostenlos starten →